Biocardiainc Stock Current Valuation
| BCDA Stock | USD 0.38 0.01 2.56% |
Valuation analysis of BiocardiaInc helps investors to measure BiocardiaInc's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The current year's Enterprise Value Over EBITDA is expected to grow to -1.21. The current year's Enterprise Value Multiple is expected to grow to -1.21. Fundamental drivers impacting BiocardiaInc's valuation include:
Price Book 10.6661 | Enterprise Value 10.4 M | Enterprise Value Ebitda (0.92) | Price Sales 21.8512 | Enterprise Value Revenue 22.2956 |
Undervalued
Today
Please note that BiocardiaInc's price fluctuation is dangerous at this time. Calculation of the real value of BiocardiaInc is based on 3 months time horizon. Increasing BiocardiaInc's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for BiocardiaInc is useful when determining the fair value of the BiocardiaInc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of BiocardiaInc. Since BiocardiaInc is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BiocardiaInc Stock. However, BiocardiaInc's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.38 | Real 1.28 | Target 4.0 | Hype 0.38 | Naive 0.39 |
The real value of BiocardiaInc Stock, also known as its intrinsic value, is the underlying worth of BiocardiaInc Company, which is reflected in its stock price. It is based on BiocardiaInc's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of BiocardiaInc's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence BiocardiaInc's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of BiocardiaInc helps investors to forecast how BiocardiaInc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BiocardiaInc more accurately as focusing exclusively on BiocardiaInc's fundamentals will not take into account other important factors: BiocardiaInc Company Current Valuation Analysis
BiocardiaInc's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current BiocardiaInc Current Valuation | 10.37 M |
Most of BiocardiaInc's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BiocardiaInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
BiocardiaInc Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for BiocardiaInc is extremely important. It helps to project a fair market value of BiocardiaInc Stock properly, considering its historical fundamentals such as Current Valuation. Since BiocardiaInc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BiocardiaInc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BiocardiaInc's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, BiocardiaInc has a Current Valuation of 10.37 M. This is 99.93% lower than that of the Biotechnology sector and 99.78% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.94% higher than that of the company.
BiocardiaInc Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BiocardiaInc's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BiocardiaInc could also be used in its relative valuation, which is a method of valuing BiocardiaInc by comparing valuation metrics of similar companies.BiocardiaInc is currently under evaluation in current valuation category among related companies.
BiocardiaInc Current Valuation Drivers
We derive many important indicators used in calculating different scores of BiocardiaInc from analyzing BiocardiaInc's financial statements. These drivers represent accounts that assess BiocardiaInc's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of BiocardiaInc's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 20.8M | 35.0M | 32.8M | 37.0M | 14.1M | 13.4M | |
| Enterprise Value | 16.3M | 14.2M | 21.8M | 31.3M | 14.3M | 13.6M |
BiocardiaInc Fundamentals
| Return On Equity | -7.04 | ||||
| Return On Asset | -1.14 | ||||
| Operating Margin | (160.31) % | ||||
| Current Valuation | 10.37 M | ||||
| Shares Outstanding | 26.87 M | ||||
| Shares Owned By Insiders | 29.95 % | ||||
| Shares Owned By Institutions | 7.75 % | ||||
| Number Of Shares Shorted | 271.17 K | ||||
| Price To Earning | (11.00) X | ||||
| Price To Book | 10.67 X | ||||
| Price To Sales | 21.85 X | ||||
| Revenue | 477 K | ||||
| Gross Profit | (7.48 M) | ||||
| EBITDA | (11.23 M) | ||||
| Net Income | (11.57 M) | ||||
| Cash And Equivalents | 8.61 M | ||||
| Cash Per Share | 0.49 X | ||||
| Total Debt | 1.31 M | ||||
| Debt To Equity | 0.26 % | ||||
| Current Ratio | 3.00 X | ||||
| Book Value Per Share | (0.07) X | ||||
| Cash Flow From Operations | (9.97 M) | ||||
| Short Ratio | 1.98 X | ||||
| Earnings Per Share | (0.55) X | ||||
| Target Price | 4.0 | ||||
| Number Of Employees | 16 | ||||
| Beta | 1.49 | ||||
| Market Capitalization | 10.21 M | ||||
| Total Asset | 2.99 M | ||||
| Retained Earnings | (152.18 M) | ||||
| Working Capital | (2.15 M) | ||||
| Current Asset | 19.48 M | ||||
| Current Liabilities | 330 K | ||||
| Net Asset | 2.99 M |
About BiocardiaInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BiocardiaInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BiocardiaInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BiocardiaInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with BiocardiaInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BiocardiaInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiocardiaInc will appreciate offsetting losses from the drop in the long position's value.Moving together with BiocardiaInc Stock
| 0.63 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.66 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
Moving against BiocardiaInc Stock
| 0.73 | QLI | Qilian International | PairCorr |
| 0.55 | SNDL | SNDL Inc Financial Report 20th of May 2024 | PairCorr |
| 0.53 | CGC | Canopy Growth Corp Financial Report 27th of June 2024 | PairCorr |
| 0.49 | IMCC | Im Cannabis Corp | PairCorr |
The ability to find closely correlated positions to BiocardiaInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BiocardiaInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BiocardiaInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BiocardiaInc to buy it.
The correlation of BiocardiaInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BiocardiaInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BiocardiaInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BiocardiaInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out BiocardiaInc Piotroski F Score and BiocardiaInc Altman Z Score analysis. For information on how to trade BiocardiaInc Stock refer to our How to Trade BiocardiaInc Stock guide.Note that the BiocardiaInc information on this page should be used as a complementary analysis to other BiocardiaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for BiocardiaInc Stock analysis
When running BiocardiaInc's price analysis, check to measure BiocardiaInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BiocardiaInc is operating at the current time. Most of BiocardiaInc's value examination focuses on studying past and present price action to predict the probability of BiocardiaInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BiocardiaInc's price. Additionally, you may evaluate how the addition of BiocardiaInc to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is BiocardiaInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BiocardiaInc. If investors know BiocardiaInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BiocardiaInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.55) | Revenue Per Share 0.023 | Quarterly Revenue Growth (0.88) | Return On Assets (1.14) | Return On Equity (7.04) |
The market value of BiocardiaInc is measured differently than its book value, which is the value of BiocardiaInc that is recorded on the company's balance sheet. Investors also form their own opinion of BiocardiaInc's value that differs from its market value or its book value, called intrinsic value, which is BiocardiaInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BiocardiaInc's market value can be influenced by many factors that don't directly affect BiocardiaInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BiocardiaInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if BiocardiaInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BiocardiaInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.